These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 36074935)

  • 21. Improvement and decline in vision with gene therapy in childhood blindness.
    Jacobson SG; Cideciyan AV; Roman AJ; Sumaroka A; Schwartz SB; Heon E; Hauswirth WW
    N Engl J Med; 2015 May; 372(20):1920-6. PubMed ID: 25936984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy reforms photoreceptor structure and restores vision in NPHP5-associated Leber congenital amaurosis.
    Aguirre GD; Cideciyan AV; Dufour VL; Ripolles-García A; Sudharsan R; Swider M; Nikonov R; Iwabe S; Boye SL; Hauswirth WW; Jacobson SG; Beltran WA
    Mol Ther; 2021 Aug; 29(8):2456-2468. PubMed ID: 33781914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for Leber congenital amaurosis: advances and future directions.
    Hufnagel RB; Ahmed ZM; Corrêa ZM; Sisk RA
    Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1117-28. PubMed ID: 22644094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inherited retinal dystrophy: first results of RPE65 gene replacement therapy in Russia].
    Kadyshev VV; Zolnikova IV; Khalanskaya OV; Stepanova AA; Kutsev SI
    Vestn Oftalmol; 2022; 138(4):48-57. PubMed ID: 36004591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dawn of ocular gene therapy: implications for molecular diagnosis in retinal disease.
    Zaneveld J; Wang F; Wang X; Chen R
    Sci China Life Sci; 2013 Feb; 56(2):125-33. PubMed ID: 23393028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Let There Be Light: Gene and Cell Therapy for Blindness.
    Dalkara D; Goureau O; Marazova K; Sahel JA
    Hum Gene Ther; 2016 Feb; 27(2):134-47. PubMed ID: 26751519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasticity of the human visual system after retinal gene therapy in patients with Leber's congenital amaurosis.
    Ashtari M; Zhang H; Cook PA; Cyckowski LL; Shindler KS; Marshall KA; Aravand P; Vossough A; Gee JC; Maguire AM; Baker CI; Bennett J
    Sci Transl Med; 2015 Jul; 7(296):296ra110. PubMed ID: 26180100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy: perspectives from young adults with Leber's congenital amaurosis.
    Napier MP; Selvan K; Hayeems RZ; Shuman C; Chitayat D; Sutherland JE; Day MA; Héon E
    Eye (Lond); 2022 Nov; 36(11):2088-2093. PubMed ID: 34531550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA-Based Therapeutic Strategies for Inherited Retinal Dystrophies.
    Garanto A
    Adv Exp Med Biol; 2019; 1185():71-77. PubMed ID: 31884591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on gene therapies in pediatric ophthalmology.
    Bremond-Gignac D; Robert MP; Daruich A
    Arch Pediatr; 2023 Nov; 30(8S1):8S41-8S45. PubMed ID: 38043982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy using self-complementary Y733F capsid mutant AAV2/8 restores vision in a model of early onset Leber congenital amaurosis.
    Ku CA; Chiodo VA; Boye SL; Goldberg AF; Li T; Hauswirth WW; Ramamurthy V
    Hum Mol Genet; 2011 Dec; 20(23):4569-81. PubMed ID: 21880665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis.
    Hussain RM; Tran KD; Maguire AM; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):661-663. PubMed ID: 31671202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.
    Simonelli F; Maguire AM; Testa F; Pierce EA; Mingozzi F; Bennicelli JL; Rossi S; Marshall K; Banfi S; Surace EM; Sun J; Redmond TM; Zhu X; Shindler KS; Ying GS; Ziviello C; Acerra C; Wright JF; McDonnell JW; High KA; Bennett J; Auricchio A
    Mol Ther; 2010 Mar; 18(3):643-50. PubMed ID: 19953081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AAV-mediated gene therapy for the treatment of retinal diseases.
    Rolling F
    Curr Gene Ther; 2010 Oct; 10(5):318. PubMed ID: 20874705
    [No Abstract]   [Full Text] [Related]  

  • 35. Gene delivery to cone photoreceptors by subretinal injection of rAAV2/6 in the mouse retina.
    Hori T; Fukutome M; Maejima C; Matsushima H; Kobayashi K; Kitazawa S; Kitahara R; Kitano K; Kobayashi K; Moritoh S; Koike C
    Biochem Biophys Res Commun; 2019 Jul; 515(1):222-227. PubMed ID: 31146917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene and cell-based therapies for inherited retinal disorders: An update.
    Sengillo JD; Justus S; Tsai YT; Cabral T; Tsang SH
    Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):349-366. PubMed ID: 27862925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Structural Outcomes of Late-Stage RPE65 Gene Therapy.
    Gardiner KL; Cideciyan AV; Swider M; Dufour VL; Sumaroka A; Komáromy AM; Hauswirth WW; Iwabe S; Jacobson SG; Beltran WA; Aguirre GD
    Mol Ther; 2020 Jan; 28(1):266-278. PubMed ID: 31604676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of Leber congenital amaurosis: a model to understand human retinal development.
    Koenekoop RK
    Surv Ophthalmol; 2004; 49(4):379-98. PubMed ID: 15231395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Jeremiah Metzger Lecture: gene therapy for inherited disorders: from Christmas disease to Leber's amaurosis.
    High KA
    Trans Am Clin Climatol Assoc; 2009; 120():331-59. PubMed ID: 19768188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy for RPE65-related retinal disease.
    Miraldi Utz V; Coussa RG; Antaki F; Traboulsi EI
    Ophthalmic Genet; 2018 Dec; 39(6):671-677. PubMed ID: 30335549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.